Association between hypnotizability and the catechol-O-methyltransferase (COMT) polymorphism

International Journal of Clinical and Experimental Hypnosis

Volumn 58, Issue 3, 2010, Pages 301-315

  Szekely, Anna ^a   Kovacs Nagy, Reka ^b   Banyai, Eva I ^a   Gösi Greguss, Anna C ^a   Varga, Katalin ^a   Halmai, Zsuzsa ^a   Ronai, Zsolt ^b   Sasvari Szekely, Maria ^b  

^a INSTITUTE FOR PSYCHOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ARTICLE; BRAIN FUNCTION; COGNITION; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYPNOTIC SUSCEPTIBILITY; MALE; NORMAL HUMAN; PHENOTYPE; PREFRONTAL CORTEX; PROTEIN DEGRADATION; PSYCHOMETRY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; CATECHOL O-METHYLTRANSFERASE; COGNITION; DOPAMINE; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYPNOSIS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; REPRODUCIBILITY OF RESULTS; SEX FACTORS; YOUNG ADULT;

EID: 77952976569     PISSN: 00207144     EISSN: 17445183     Source Type: Journal    
DOI: 10.1080/00207141003760827     Document Type: Article

References (35)

1. Bányai, É. I. (2008). A hipnózis szociál-pszichobiológiai modellje [The socialpsychobiological model of hypnosis]. In É. I. Bányai & L. Benczúr (Eds.), A hipnózis és hipnoterápia alapjai [The basis of hypnosis and hypnotherapy] (pp. 379-445). Budapest, Hungary: ELTE Eötvös Kiadó.
2. Bauman, D. E., & Bul, P. I. (1981). [Human inheritability of hypnotizability]. Genetika, 17, 352-356.
3. Bilder, R. M., Volavka, J., Czobor, P., Malhotra, A. K., Kennedy, J. L., Ni, X., et al. (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry, 52, 701-707.
4. Bowers, K. S. (1993). The Waterloo-Stanford Group C (WSGC) scale of hypnotic susceptibility: Normative and comparative data. International Journal of Clinical and Experimental Hypnosis, 41, 35-46.
5. Bowers, K. S. (1998). Waterloo-Stanford Group Scale of Hypnotic Susceptibility, Form C: Manual and response booklet. International Journal of Clinical and Experimental Hypnosis, 46, 250-268.
6. Carvalho, C., Kirsch, I., Mazzoni, G., & Leal, I. (2008). Portuguese norms for theWaterloo-Stanford Group C (WSGC) scale of hypnotic susceptibility. International Journal of Clinical and Experimental Hypnosis, 56, 295-305.
7. Diamond, A., Briand, L., Fossella, J., & Gehlbach, L. (2004). Genetic and neurochemical modulation of prefrontal cognitive functions in children. American Journal of Psychiatry, 161(1), 125-132.
8. Goldberg, T. E., Egan, M. F., Gscheidle, T., Coppola, R., Weickert, T., Kolachana, B. S., et al. (2003). Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry, 60, 889-896.
9. Hilgard, E. R. (1965). Hypnotic susceptibility. New York: Harcourt, Brace & World.
10. Józsa, E., Bányai, É. I., Métneki, J., Ǧosi-Greguss, A. C., Suhai-Hodász, G., & Varga, K. (2004, October). Hypnosis interaction from an evolutionary perspective: The genetic basis of hypnotic susceptibility. Paper presented at the 16th International Congress on Hypnosis and Hypnotherapy, Singapore.
11. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250.
12. Lichtenberg, P., Bachner-Melman, R., Ebstein, R. P., & Crawford, H. J. (2004). Hypnotic susceptibility: Multidimensional relationships with Cloninger's Tridimensional Personality Questionnaire, COMT polymorphisms, absorption, and attentional characteristics. International Journal of Clinical and Experimental Hypnosis, 52, 47-72.
13. Lichtenberg, P., Bachner-Melman, R., Gritsenko, I., & Ebstein, R. P. (2000). Exploratory association study between catechol-O-methyltransferase (COMT) high/low enzyme activity polymorphism and hypnotizability. American Journal of Medical Genetics, 96, 771-774.
14. Malhotra, A. K., Kestler, L. J., Mazzanti, C., Bates, J. A., Goldberg, T., & Goldman, D. (2002). A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry, 159, 652-654.
15. Mannisto, P. T., & Kaakkola, S. (1999). Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews, 51, 593-628.
16. Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., et al. (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences, 100, 6186-6191.
17. Morgan, A. H. (1973). The heritability of hypnotic susceptibility in twins. Journal of Abnormal Psychology, 82, 55-61.
18. Morgan, A. H., Hilgard, E. R., & Davert, E. C. (1970). The heritability of hypnotic susceptibility of twins: A preliminary report. Behavior Genetics, 1, 213-224.
19. Morgan, A. H., Johnson, D. L., & Hilgard, E. R. (1974). The stability of hypnotic susceptibility: A longitudinal study. International Journal of Clinical and Experimental Hypnosis, 22, 249-257.
20. Mukherjee, N., Kidd, K. K., Pakstis, A. J., Speed,W. C., Li, H., Tarnok, Z., et al. (2010). The complex global pattern of genetic variation and linkage disequilibrium at catechol-Omethyltransferase. Molecular Psychiatry 15, 216-225.
21. Piccione, C., Hilgard, E. R., & Zimbardo, P. G. (1989). On the degree of stability of measured hypnotizability over a 25-year period. Journal of Personality and Social Psychology, 56, 289-295.
22. Raz, A. (2005). Attention and hypnosis: Neural substrates and genetic associations of two converging processes. International Journal of Clinical and Experimental Hypnosis, 53, 237-258.
23. Raz, A., Fan, J., & Posner, M. I. (2006). Neuroimaging and genetic associations of attentional and hypnotic processes. Journal of Physiology - Paris, 99, 483-491.
24. Raz, A., Fossella, J. A., McGuinness, P., Sommer, T., & Posner, M. I. (2003, March). Using genetic association assays to assess the role of dopaminergic neuromodulation in attentional and hypnotic phenomena. Paper presented at the Cognitive Neuroscience Society, New York, NY.
25. Raz, A., Shapiro, T., Fan, J., & Posner, M. I. (2002). Hypnotic suggestion and the modulation of Stroop interference. Archives of General Psychiatry, 59, 1155-1161.
26. Spiegel, D. (2003).Negative and positive visual hypnotic hallucinations: Attending inside and out. International Journal of Clinical and Experimental Hypnosis, 51, 130-146.
27. Spiegel, D., & King, R. (1992). Hypnotizability and CSF HVA levels among psychiatric patients. Biological Psychiatry, 31(1), 95-98.
28. Starr, J. M., Fox, H., Harris, S. E., Deary, I. J., &Whalley, L. J. (2007). COMT genotype and cognitive ability: A longitudinal aging study. Neuroscience Letters, 421(1), 57-61.
29. Syvanen, A. C., Tilgmann, C., Rinne, J., & Ulmanen, I. (1997). Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics, 7(1), 65-71.
30. Szekely, A., Ronai, Z., Ǧosiné Greguss, A., Varga, K., & Bányai, É. (2006, August). Cognitive, personality and genetic factors of hypnotic susceptibility. Paper presented at the XVII International Congress of Hypnosis, Acapulco, Guerrero, México.
31. Tarnok, Z., Ronai, Z., Gervai, J., Kereszturi, E., Gadoros, J., Sasvari-Szekely, M., et al. (2007). Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3' UTR polymorphism of the dopamine transporter gene. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B, 900-905.
32. Thierry, A. M., Tassin, J. P., Blanc, G., & Glowinski, J. (1976). Selective activation of mesocortical DA system by stress. Nature, 263(5574), 242-244.
33. Tunbridge, E. M., Bannerman, D. M., Sharp, T., & Harrison, P. J. (2004). Catechol-omethyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. Journal of Neuroscience, 24, 5331-5335.
34. Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006). Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry, 60, 141-151.
35. Weitzenhoffer, A. M., & Hilgard, E. R. (1962). Stanford Hypnotic Susceptibility Scale, Form C. Palo Alto, CA: Consulting Psychologists.